The Biosimilars Forum
The Biosimilars Forum's network
9 people4 organisationsi9 people and 4 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (9). Violet dotted lines (4) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
9 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 9 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Brian McCarthy | Director | 2024 | 2 yrs |
| Brian McCormick | Director | 2024 | 2 yrs |
| David Sanders | Director | 2020 | 6 yrs |
| Gillian Woollett | Director | 2022 | 4 yrs |
| Jon Martin | Treasurer & | 2021 | 5 yrs |
| Len Arensault | Director (Ex | 2023 | 3 yrs |
| Margaret Davis-Cerone | Director (Ex | 2023 | 3 yrs |
| Nimish Shah | Director | 2024 | 2 yrs |
| Sean McGowan | Director | 2024 | 2 yrs |
Under 5 years5 to 6 years6 years or more
Officers and senior leadership
2 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Juliana Reed | Executive Di | since 2022 |
| Meaghan Smith | Executive Di | since 2020 |
Pay and hours
year to 31 December 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Juliana Reed | Executive Di | 40 | $0 | ||
| Jon Martin | Treasurer & | 0.9 | $0 | ||
| Margaret Davis-Cerone | Director (Ex | 0.9 | $0 | ||
| Len Arensault | Director (Ex | 0.9 | $0 | ||
| Sean McGowan | Director | 0.5 | $0 | ||
| Brian McCarthy | Director | 0.5 | $0 | ||
| Brian McCormick | Director | 0.5 | $0 | ||
| Gillian Woollett | Director | 0.5 | $0 | ||
| Sandy Hoang | Director | 0.5 | $0 | ||
| Josh Salsi | Director | 0.5 | $0 |
No pay was reported for anyone in Part VII on this return.
About
- Legal name
- The Biosimilars Forum
- EIN
- 810762544
- Address
- 20855 Saber Jet Pl, Ashburn, VA, 20147-6268
- State
- Virginia
- Mission
- To advance biosimilars in the united states with the intent of expanding access and availability of biological medicines and improving health care. (as filed on the Form 990)
- Activity (NTEE)
- S41 Community improvement and capacity building
- IRS classification
- 501(c)06 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Community Improvement & Capacity Building
- Size band
- 6 (IRS master file code)
- Formed
- 2015
- Principal officer
- Juliana Reed (as named on the Form 990)
- IRS ruling date
- 1 April 2016
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 7, latest 2024
Most connected
Longest observed on the filings
≥6years on the filingsDavid Sanders
≥5years on the filingsJon Martin
≥4years on the filingsGillian Woollett
≥3years on the filingsLen Arensault
Latest return
year to 31 December 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2025. US dollars, as filed.- Total assets
- $3m
- Total liabilities
- $2.5m
- Net assets or fund balances
- $505k
- Contributions and grants received
- $2.3m
- Program service revenue
- $0
- Employees
- 0
- Volunteers
- 8
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $2.1m | $2m | $137k |
As filed on the IRS Form 990. US dollars.